• EarlyCDT®-Lung Kit is a CE marked test for the in vitro detection of a panel of seven lung cancer autoantibodies in humans to aid in the early detection of lung cancer in moderate and high risk individuals (CE marking)
  • EarlyCDT®-Lung Kit enables professional laboratories to run our blood test for lung cancer on standard ELISA-96 well-Microplate instruments
  • The kit is available world-wide outside the US, subject to local regulations
  • The kit is CE marked and it meets the strict EU standards of manufacturing and quality control of the In Vitro Diagnostics Medical Devices Directive 98/79/EC
  • The kit is distributed in numerous countries, see list of distributors


Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept